1932

Abstract

▪ Abstract 

Antibiotics target ribosomes at distinct locations within functionally relevant sites. They exert their inhibitory action by diverse modes, including competing with substrate binding, interfering with ribosomal dynamics, minimizing ribosomal mobility, facilitating miscoding, hampering the progression of the mRNA chain, and blocking the nascent protein exit tunnel. Although the ribosomes are highly conserved organelles, they possess subtle sequence and/or conformational variations. These enable drug selectivity, thus facilitating clinical usage. The structural implications of these differences were deciphered by comparisons of high-resolution structures of complexes of antibiotics with ribosomal particles from eubacteria resembling pathogens and from an archaeon that shares properties with eukaryotes. The various antibiotic-binding modes detected in these structures demonstrate that members of antibiotic families possessing common chemical elements with minute differences might bind to ribosomal pockets in significantly different modes, governed by their chemical properties. Similarly, the nature of seemingly identical mechanisms of drug resistance is dominated, directly or via cellular effects, by the antibiotics' chemical properties. The observed variability in antibiotic binding and inhibitory modes justifies expectations for structurally based improved properties of existing compounds as well as for the discovery of novel drug classes.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.biochem.74.082803.133130
2005-07-07
2024-04-13
Loading full text...

Full text loading...

/deliver/fulltext/bi/74/1/annurev.biochem.74.082803.133130.html?itemId=/content/journals/10.1146/annurev.biochem.74.082803.133130&mimeType=html&fmt=ahah

Literature Cited

  1. Sigmund CD, Ettayebi M, Morgan EA. 1984. Nucleic Acids Res. 12:4653–63
  2. Courvalin P, Ounissi H, Arthur M. 1985. J. Antimicrob. Chemother. 16:91–100
  3. Weisblum B. 1995. Antimicrob. Agents Chemother. 39:577–85
  4. Vazquez D. 1979. Mol. Biol. Biochem. Biophys. 30:1–312
  5. Cundliffe E. 1981. In The Molecular Basis of Antibiotic Action ed. EF Gale, E Cundliffe, PE Reynolds, MH Richmond, MJ Waring MJ pp. 419–39 London: Wiley
  6. Cundliffe E. 1981. See Ref. 5 pp. 402–547
  7. Spahn CM, Prescott CD. 1996. J. Mol. Med. 74:423–39
  8. Yonath A, Bashan A. 2004. Annu. Rev. Microbiol. 58:233–51
  9. Schluenzen F, Tocilj A, Zarivach R, Harms J, Gluehmann M. et al. 2000. Cell 102:615–23
  10. Wimberly BT, Brodersen DE, Clemons WM Jr, Morgan-Warren RJ, Carter AP. et al. 2000. Nature 407:327–39
  11. Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. 2000. Science 289:905–20
  12. Yusupov MM, Yusupova GZ, Baucom A, Lieberman K, Earnest TN. et al. 2001. Science 292:883–96
  13. Harms J, Schluenzen F, Zarivach R, Bashan A, Gat S. et al. 2001. Cell 107:679–88
  14. Carter AP, Clemons WM, Brodersen DE, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. Nature 407:340–48
  15. Brodersen DE, Clemons WM Jr, Carter AP, Morgan-Warren RJ, Wimberly BT, Ramakrishnan V. 2000. Cell 103:1143–54
  16. Pioletti M, Schluenzen F, Harms J, Zarivach R, Gluehmann M. et al. 2001. EMBO J. 20:1829–39
  17. Schluenzen F, Zarivach R, Harms J, Bashan A, Tocilj A. et al. 2001. Nature 413:814–21
  18. Schluenzen F, Harms JM, Franceschi F, Hansen HA, Bartels H. et al. 2003. Structure 11:329–38
  19. Hansen JL, Ippolito JA, Ban N, Nissen P, Moore PB, Steitz TA. 2002. Mol. Cell 10:117–28
  20. Hansen JL, Moore PB, Steitz TA. 2003. J. Mol. Biol. 330:1061–75
  21. Berisio R, Schluenzen F, Harms J, Bashan A, Auerbach T. et al. 2003. Nat. Struct. Biol. 10:366–70
  22. Berisio R, Harms J, Schluenzen F, Zarivach R, Hansen HA. et al. 2003. J. Bacteriol. 185:4276–79
  23. Harms J, Schluenzen F, Fucini P, Bartels H, Yonath A. 2004. BMC Biol. 2:1741–47
  24. Schluenzen F, Pyetan E, Yonath A, Harms J. 2004. Mol. Microbiol. 54:1287–94
  25. Auerbach T, Bashan A, Harms J, Schluenzen F, Zarivach R. et al. 2002. Curr. Drug Targets—Infect. Disord. 2:169–86
  26. Knowles DJ, Foloppe N, Matassova NB, Murchie AI. 2002. Curr. Opin. Pharmacol. 2:501–6
  27. Gaynor M, Mankin AS. 2003. Curr. Top Med. Chem. 3:949–61
  28. Poehlsgaard J, Douthwaite S. 2003. Curr. Opin. Investig. Drugs 4:140–48
  29. Auerbach T, Bashan A, Yonath A. 2004. Trends Biotechnol. 22:570–76
  30. Pfister P, Jenni S, Poehlsgaard J, Thomas A, Douthwaite S. et al. 2004. J. Mol. Biol. 342:1569–81
  31. Bashan A, Agmon I, Zarivach R, Schluenzen F, Harms J. et al. 2003. Mol. Cell 11:91–102
  32. Agmon I, Amit M, Auerbach T, Bashan A, Baram D. et al. 2004. FEBS Lett. 567:20–26
  33. Yonath A. 2002. Annu. Rev. Biophys. Biomol. Struct. 31:257–73
  34. Lodmell JS, Dahlberg AE. 1997. Science 277:1262–67
  35. Fourmy D, Recht MI, Blanchard SC, Puglisi JD. 1996. Science 274:1367–71
  36. Vicens Q, Westhof E. 2001. Structure 9:647–58
  37. Lynch SR, Gonzalez RL, Puglisi JD. 2003. Structure 11:43–53
  38. Fourmy D, Recht MI, Puglisi JD. 1998. J. Mol. Biol. 277:347–62
  39. Bashan A, Zarivach R, Schluenzen F, Agmon I, Harms J. et al. 2003. Biopolymers 70:19–41
  40. Agmon I, Auerbach T, Baram D, Bartels H, Bashan A. et al. 2003. Eur. J. Biochem. 270:2543–56
  41. Zarivach R, Bashan A, Berisio R, Harms J, Auerbach T. et al. 2004. J. Phys. Org. Chem. 17:901–12
  42. Baram D, Yonath A. 2005. FEBS Letters. 579:948–54
  43. Mankin AS, Garrett RA. 1991. J. Bacteriol. 173:3559–63
  44. Shaw WV, Leslie AG. 1991. Annu. Rev. Biophys. Biophys. Chem. 20:363–86
  45. Izard T, Ellis J. 2000. EMBO J. 19:2690–700
  46. Douthwaite S. 1992. Nucleic Acids Res. 20:4717–20
  47. Kucers A, Bennett N, Kemp R. 1987. In The Use of Antibiotics ed. A Kucers, N Bennett, R Kemp pp. 819–50 Philadelphia: Heinemann
  48. Bacque E, Pautrat F, Zard SZ. 2002. Chem. Commun.2312–13
  49. Springer DM, Sorenson ME, Huang S, Connolly TP, Bronson JJ. et al. 2003. Bioorg. Med. Chem. Lett. 13:1751–53
  50. Kavanagh F, Hervey A, Robbins WJ. 1951. Proc. Natl. Acad. Sci. USA 37:570–74
  51. Egger H, Reinshagen H. 1976. J. Antibiot. 29:923–27
  52. Hogenauer G. 1975. Eur. J. Biochem. 52:93–98
  53. Poulsen SM, Karlsson M, Johansson LB, Vester B. 2001. Mol. Microbiol. 41:1091–99
  54. Pringle M, Poehlsgaard J, Vester B, Long KS. 2004. Mol. Microbiol. 54:1295–306
  55. Hogenauer G, Egger H, Ruf C, Stumper B. 1981. Biochemistry 20:546–52
  56. Milligan RA, Unwin PN. 1986. Nature 319:693–95
  57. Yonath A, Leonard KR, Wittmann HG. 1987. Science 236:813–16
  58. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. 2000. Science 289:920–30
  59. Nakatogawa H, Ito K. 2002. Cell 108:629–36
  60. Gong F, Yanofsky C. 2002. Science 297:1864–67
  61. Woolhead CA, McCormick PJ, Johnson AE. 2004. Cell 116:725–36
  62. Andersson S, Kurland CG. 1987. Biochimie 69:901–4
  63. Contreras A, Vazquez D. 1977. Eur. J. Biochem. 74:539–47
  64. Tai PC, Wallace BJ, Davis BD. 1974. Biochemistry 13:4653–59
  65. Tenson T, Lovmar M, Ehrenberg M. 2003. J. Mol. Biol. 330:1005–14
  66. Garza-Ramos G, Xiong L, Zhong P, Mankin A. 2001. J. Bacteriol. 183:6898–907
  67. Tenson T, Ehrenberg M. 2002. Cell 108:591–94
  68. Menninger JR, Otto DP. 1982. Antimicrob. Agents Chemother. 21:811–18
  69. Otaka T, Kaji A. 1975. Proc. Natl. Acad. Sci. USA 72:2649–52
  70. Douthwaite S, Hansen LH, Mauvais P. 2000. Mol. Microbiol. 36:183–93
  71. Vester B, Douthwaite S. 2001. Antimicrob. Agents Chemother. 45:1–12
  72. Blondeau JM, DeCarolis E, Metzler KL, Hansen GT. 2002. Expert Opin. Investig. Drugs 11:189–215
  73. Le Noc P, Croize J, Bryskier A, Le Noc D, Robert J. 1989. Pathol. Biol. 37:553–59
  74. Bryskier A, Butzler JP, Neu HC, Tulkens PM. eds. 1993. Macrolides-Chemistry, Pharmacology, and Clinical Uses Paris: Blackwell
  75. Poulsen SM, Kofoed C, Vester B. 2000. J. Mol. Biol. 304:471–81
  76. Alvarez-Elcoro S, Enzler MJ. 1999. Mayo Clin. Proc. 74:613–34
  77. Champney WS, Tober CL. 2000. Curr. Microbiol. 41:126–35
  78. Bryskier A. 2001. Jpn. J. Antibiot. 54:64–69
  79. Zhong P, Shortridge V. 2001. Curr. Drug Targets Infect. Disord. 1:125–31
  80. Wu YJ, Su WG. 2001. Curr. Med. Chem. 8:1727–58
  81. Zhanel GG, Walters M, Noreddin A, Vercaigne LM, Wierzbowski A. et al. 2002. Drugs 62:1771–804
  82. Ackermann G, Rodloff AC. 2003. J. Antimicrob. Chemother. 51:497–511
  83. Douthwaite S, Champney WS. 2001. J. Antimicrob. Chemother. 48:1–8
  84. Xiong L, Shah S, Mauvais P, Mankin AS. 1999. Mol. Microbiol. 31:633–39
  85. Hansen LH, Mauvais P, Douthwaite S. 1999. Mol. Microbiol. 31:623–31
  86. Bingen E, Leclercq R, Fitoussi F, Brahimi N, Malbruny B. et al. 2002. Antimicrob. Agents Chemother. 46:1199–203
  87. Vimberg V, Xiong L, Bailey M, Tenson T, Mankin A. 2004. Mol. Microbiol. 54:376–85
  88. Tenson T, DeBlasio A, Mankin A. 1996. Proc. Natl. Acad. Sci. USA 93:5641–46
  89. Tenson T, Mankin AS. 2001. Peptides 22:1661–68
  90. Tripathi S, Kloss PS, Mankin AS. 1998. J. Biol. Chem. 273:20073–77
  91. Mao JC, Robishaw EE. 1971. Biochemistry 10:2054–61
  92. Porse BT, Garrett RA. 1999. J. Mol. Biol. 286:375–87
  93. Porse BT, Kirillov SV, Awayez MJ, Ottenheijm HC, Garrett RA. 1999. Proc. Natl. Acad. Sci. USA 96:9003–8
  94. Goldberg IH, Mitsugi K. 1966. Biochem. Biophys. Res. Commun. 23:453–59
  95. Monro RE, Celma ML, Vazquez D. 1969. Nature 222:356–58
  96. Zamir A, Miskin R, Vogel Z, Elson D. 1974. Methods Enzymol. 30:406–26
  97. Bayfield MA, Dahlberg AE, Schulmeister U, Dorner S, Barta A. 2001. Proc. Natl. Acad. Sci. USA 98:10096–101
  98. Moore PB, Steitz TA. 2003. RNA 9:155–59
  99. Kaper JB, Nataro JP, Mobley HL. 2004. Nat. Rev. Microbiol. 2:123–40
  100. Tan GT, DeBlasio A, Mankin AS. 1996. J. Mol. Biol. 261:222–30
  101. Boettger EC, Springer B, Prammananan T, Kidan Y, Sander P. 2001. EMBO Rep. 2:318–23
  102. Wittmann HG, Stoffler G, Apirion D, Rosen L, Tanaka K. et al. 1973. Mol. Gen. Genet. 127:175–89
  103. Chittum HS, Champney WS. 1994. J. Bacteriol. 176:6192–98
  104. Canu A, Abbas A, Malbruny B, Sichel F, Leclercq R. 2004. Antimicrob. Agents Chemother. 48:297–304
  105. Gabashvili IS, Gregory ST, Valle M, Grassucci R, Worbs M. et al. 2001. Mol. Cell 8:181–88
  106. Davydova N, Streltsov V, Wilce M, Liljas A, Garber M. 2002. J. Mol. Biol. 322:635–44
  107. Gregory ST, Dahlberg AE. 1999. J. Mol. Biol. 289:827–34
  108. Bozdogan B, Appelbaum PC, Kelly LM, Hoellman DB, Tambic-Andrasevic A. et al. 2003. Clin. Microbiol. Infect. 9:741–45
  109. Pereyre S, Gonzalez P, De Barbeyrac B, Darnige A, Renaudin H. et al. 2002. Antimicrob. Agents Chemother. 46:3142–50
  110. Wilschanski M, Yahav Y, Yaacov Y, Blau H, Bentur L. et al. 2003. N. Engl. J. Med. 349:1433–41
/content/journals/10.1146/annurev.biochem.74.082803.133130
Loading
/content/journals/10.1146/annurev.biochem.74.082803.133130
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error